Minireviews
Copyright ©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 103807
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103807
Table 1 Significance of serum sodium and chloride in patients with advanced liver cirrhosis
Parameter
Serum sodium (Na+)
Serum chloride (Cl-)
Primary roleOsmotic balance & water distributionRenal salt sensing & acid-base homeostasis
Pathophysiology in cirrhosis/liver failureAffected by RAAS, AVP, splanchnic vasodilationInvolvement in renal salt-sensing mechanisms, tubuloglomerular feedback & renin release
Common disturbanceHyponatremia (< 130 mEq/L), often dilutionalHypochloremia (< 98 mEq/L)
Prognostic roleHyponatremia alone or in conjunction with MELD predicts short-term mortalityIndependent predictor of mortality in advanced cirrhosis/liver failure patients
Clinical outcomesHigher risk of death, hepatic decompensation, and need for liver transplantStrong correlation with ICU mortality, hepatic decompensation, and long-term prognosis
Scoring modelsIncorporated in MELD-Na for liver transplant candidatesMELD-Cl under evaluation; not yet standardised
AssociationsLinked to renal function, ascites, bilirubin, and INRCorrelates with MELD, SOFA, Child-Pugh scores, lactate, and creatinine levels
ICU prognosticationIndependent impact in severe cases declinesSuperior prognostic value even after adjustments
Therapeutic benefitCorrecting hyponatremia may improves outcomesIt remains to be seen if treating hypochloremia improves outcomes
Table 2 Studies demonstrating prognostic role of serum chloride in advanced liver disease patients, n (%)
Ref.
Study design
Patients (n)
Incidence of hypochloremia
Results
Limitations
Sumarsono et al[14], 2020Retrospective cohort389 critically ill cirrhosis157 (40.4)Hypochloremia was associated with higher in-hospital mortality (31% vs 19%, P < 0.01) as well as 180-day mortality (45.2% vs 26.7%, P < 0.0001)Retrospective design, limited generalizability due to inclusion of only ICU cohort, one-time chloride measurement, and selection bias as indicated by lower overall ICU mortality rates
Ji and Li[8], 2021Retrospective cohort1216 critically ill cirrhosis199 (16.4)Hypochloremic patients had a significantly higher ICU mortality rate compared to non-hypochloremic ones (34.2% vs 15.8%, P < 0.001). Every unit decline in chloride level predicted 6% increase in mortality (OR 0.94)Retrospective design, one-time chloride measurement, confounding variable not examined in multivariate model
Cheng et al[39], 2023Retrospective cohort182 cirrhosis patients undergoing TIPSNot statedPatients with serum chloride < 107.35 mmol/L had significantly worse survival compared to those with levels ≥ 107.35 mmol/L. Each unit decline in chloride increased the mortality by 17.7%Retrospective design, one-time chloride measurement during follow-up up to 1-year, and confounding effect of diuretics not assessed
Wang et al[2], 2022Longitudinal cohort2405 ALF patients428 (17.8)Hypochloremia group had lower 21-day transplant free survival (39% vs 50.2%, P < 0.001) and higher 28-day mortality (42.1%, P < 0.001)Dynamic measurement of chloride not done, prior fluid and diuretic therapy might have affected serum chloride levels, and long-term prognosis not assessed
Semmler et al[9], 2023Retrospective cohort891 ACLD; 181 critically ill cirrhosis138 (15) ACLD; 54 (30) critical cirrhosisSerum chloride had a significant association with ICU mortality [OR: 0.94 (95%CI: 0.90-0.97)], even after adjusting for confounders [adjusted OR: 3.20 (95%CI: 1.20-8.82)]. Those with chloride < 100 mmol/L exhibited significantly higher odds of ICU mortality than otherwiseRetrospective design, Vomiting or diarrhea or treatment (diuretics, fluids or lactulose) prior to as well as first few hours of admission might have impacted serum electrolytes